United States · FDA National Drug Code directory
JYLAMVO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81927-204_53bd9776-70ec-46f9-e063-6294a90a7011
- Product NDC
- 81927-204
- Form
- SOLUTION
- Composition / generic term
- Methotrexate
- Labeler
- SHORLA ONCOLOGY INC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20231215
- Source listing expiry
- 20271231
Source-listed ingredients
- METHOTREXATE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (81927-204-01) / 60 mL in 1 BOTTLE, GLASS · 81927-204-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →